NCT01719744View on ClinicalTrials.gov

Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
AdvancedMetastaticSoft Tissue Sarcoma
Interventions
DRUG

ENMD-2076

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01719744 - Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter